Literature DB >> 7654520

Decreased expression of gamma-aminobutyric acid type A/benzodiazepine receptor beta subunit mRNAs in brain of flurazepam-tolerant rats.

T J Zhao1, T H Chiu, H C Rosenberg.   

Abstract

The expression of GABAA/benzodiazepine beta subunit mRNAs was studied in cerebral cortex, hippocampus, and cerebellum of flurazepam-treated rats. Immediately following 4 wk of treatment, beta 2 and beta 3 subunit mRNAs were significantly reduced in cerebellum and hippocampus, whereas only beta 2 was decreased in cortex. These decreases had largely reversed 48 h following flurazepam treatment. After 2 wk of treatment, both beta 2 and beta 3 mRNAs were reduced in cerebellum, and beta 3 mRNA was reduced in hippocampus, but neither was changed in cortex. Four hours after an acute flurazepam treatment, the only change was a decrease in beta 3 mRNA in hippocampus. These results indicate that the expression of GABAA receptor beta subunit mRNAs in different brain regions is differentially regulated during chronic flurazepam treatment, and some changes occur within hours after a single large dose.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7654520     DOI: 10.1007/BF02736732

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  51 in total

1.  Reduced diazepam binding following chronic benzodiazepine treatment.

Authors:  T H Chiu; H C Rosenberg
Journal:  Life Sci       Date:  1978-09-18       Impact factor: 5.037

2.  Depression of benzodiazepine binding and diazepam potentiation of GABA-mediated inhibition after chronic exposure of spinal cord cultures to diazepam.

Authors:  P K Sher; R E Study; J Mazzetta; J L Barker; P G Nelson
Journal:  Brain Res       Date:  1983-05-23       Impact factor: 3.252

3.  Levels of GABAa receptor subunit mRNA in rat brain following flurazepam treatment.

Authors:  M C O'Donovan; P R Buckland; P McGuffin
Journal:  J Psychopharmacol       Date:  1992-01       Impact factor: 4.153

4.  Diazepam sensitizes mice to FG 7142 and reduces muscimol-stimulated 36Cl- flux.

Authors:  E Lewin; J Peris; V Bleck; N R Zahniser; R A Harris
Journal:  Pharmacol Biochem Behav       Date:  1989-06       Impact factor: 3.533

5.  Tolerance to the benzodiazepine diazepam in an animal model of anxiolytic activity.

Authors:  D N Stephens; H H Schneider
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  A gamma-aminobutyric acid/benzodiazepine receptor complex from bovine cerebral cortex. Improved purification with preservation of regulatory sites and their interactions.

Authors:  E Sigel; E A Barnard
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

7.  GABAA receptor subunit mRNA levels are differentially influenced by chronic FG 7142 and diazepam exposure.

Authors:  R J Primus; D W Gallager
Journal:  Eur J Pharmacol       Date:  1992-05-12       Impact factor: 4.432

8.  Chronic diazepam treatment produces regionally specific changes in GABA-stimulated chloride influx.

Authors:  R J Marley; D W Gallager
Journal:  Eur J Pharmacol       Date:  1989-01-17       Impact factor: 4.432

9.  Behavioral measurement of benzodiazepine tolerance and GABAergic subsensitivity in the substantia nigra pars reticulata.

Authors:  E I Tietz; H C Rosenberg
Journal:  Brain Res       Date:  1988-01-12       Impact factor: 3.252

10.  Evaluation of DNA probe removal from nylon membrane.

Authors:  K Noppinger; G Duncan; D Ferraro; S Watson; J Ban
Journal:  Biotechniques       Date:  1992-10       Impact factor: 1.993

View more
  2 in total

1.  Silent GABAA synapses during flurazepam withdrawal are region-specific in the hippocampal formation.

Authors:  P Poisbeau; S R Williams; I Mody
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha 1 subunit protein in rat cerebellar granule cells.

Authors:  M J Brown; D R Bristow
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.